Multi-state Markov models in cancer screening evaluation: a brief review and case study
暂无分享,去创建一个
D Eilstein | B Asselain | M Colonna | D. Eilstein | G. Hédelin | B. Asselain | P. Arveux | S. Duffy | C. Exbrayat | M. Colonna | S W Duffy | A. Rogel | F. Molinié | Z. Uhry | F Molinié | G Hédelin | P Arveux | Z Uhry | A Rogel | C Exbrayat | C Guldenfels | I Courtial | P Soler-Michel | P. Soler-Michel | I. Courtial | C. Guldenfels
[1] L. Tabár,et al. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. , 2003, European journal of cancer.
[2] C E Stevenson,et al. Statistical models for cancer screening , 1995, Statistical methods in medical research.
[3] J D Habbema,et al. Modelling issues in cancer screening , 1995, Statistical methods in medical research.
[4] L. Tabár,et al. Bayesian evaluation of breast cancer screening using data from two studies , 2003, Statistics in medicine.
[5] Tony Hsiu-Hsi Chen,et al. Estimation of mean sojourn time for lung cancer by chest X-ray screening with a Bayesian approach. , 2008, Lung cancer.
[6] Y Foucher,et al. A flexible semi-Markov model for interval-censored data and goodness-of-fit testing , 2010, Statistical methods in medical research.
[7] J. Faivre,et al. A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[8] L. Tabár,et al. Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases , 2000, Biometrics.
[9] S. Duffy,et al. Overdiagnosis, Sojourn Time, and Sensitivity in the Copenhagen Mammography Screening Program , 2006, The breast journal.
[10] L. Tabár,et al. Markov models of breast tumor progression: some age-specific results. , 1997, Journal of the National Cancer Institute. Monographs.
[11] S D Walter,et al. Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.
[12] S. Duffy,et al. Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. , 1998, American journal of epidemiology.
[13] Yohann Foucher,et al. A Semi‐Markov Model Based on Generalized Weibull Distribution with an Illustration for HIV Disease , 2005, Biometrical journal. Biometrische Zeitschrift.
[14] L. Tabár,et al. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. , 1995, Statistics in medicine.
[15] H Straatman,et al. Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group. , 1997, Biometrics.
[16] Harry J de Koning,et al. The MISCAN-Fadia continuous tumor growth model for breast cancer. , 2006, Journal of the National Cancer Institute. Monographs.
[17] A. Miller,et al. Estimation of age‐specific sensitivity and sojourn time in breast cancer screening studies , 2005, Statistics in medicine.
[18] Ruth Etzioni,et al. Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends , 2008, Biometrics.
[19] S. Duffy,et al. Quantitative methods for the evaluation of cancer screening , 2009 .
[20] L. Tabár,et al. Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer , 2005, Breast Cancer Research.
[21] P. Arveux,et al. Building a model to determine the cost-effectiveness of breast cancer screening in France. , 2003, European journal of cancer care.
[22] J. R. Koehler,et al. Modern Applied Statistics with S-Plus. , 1996 .
[23] J D Habbema,et al. A model for breast cancer screening , 1990, Cancer.
[24] Sylvia Plevritis,et al. Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups , 2004, Statistical methods in medical research.
[25] Yohann Foucher,et al. A semi-Markov model for multistate and interval-censored data with multiple terminal events. Application in renal transplantation. , 2007, Statistics in medicine.
[26] Odd O Aalen,et al. Breast cancer tumor growth estimated through mammography screening data , 2008, Breast Cancer Research.
[27] J. Habbema,et al. A model‐based analysis of the hip project for breast cancer screening , 1990, International journal of cancer.
[28] H. Collette,et al. Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods. , 1996, Journal of epidemiology and community health.
[29] P. Pinsky. An Early‐ and Late‐Stage Convolution Model for Disease Natural History , 2004, Biometrics.
[30] Yohann Foucher,et al. Cost‐effectiveness analysis in colorectal cancer using a semi‐Markov model , 2007, Statistics in medicine.
[31] N. Day,et al. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. , 1984, Biometrics.
[32] T. Prevost,et al. Evaluation of a selective screening for colorectal carcinoma , 1999, Cancer.
[33] L. Tabár,et al. Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49. , 1996, International journal of epidemiology.
[34] Simon G. Thompson,et al. Multistate Markov models for disease progression with classification error , 2003 .
[35] Odd O Aalen,et al. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results , 2005, Journal of medical screening.
[36] Stephen W. Duffy,et al. A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening , 1996 .
[37] H. D. de Koning,et al. Gleason score, age and screening: Modeling dedifferentiation in prostate cancer , 2006, International journal of cancer.
[38] L. Tabár,et al. Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden. , 1998, Journal of epidemiology and community health.
[39] P. Pinsky. Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing , 2001, Biometrics.
[40] Rob Boer,et al. The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..
[41] M. Zelen,et al. Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding , 1999 .
[42] J. Habbema,et al. Cost-effectiveness of cervical cancer screening: comparison of screening policies. , 2002, Journal of the National Cancer Institute.
[43] Odd O Aalen,et al. Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening , 2008, Journal of medical screening.
[44] D. Berry,et al. Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .
[45] F. Balaguer,et al. Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model. , 2008, Gastroenterologia y hepatologia.
[46] M. Zelen,et al. Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution. , 2005, Biostatistics.
[47] S. Duffy,et al. Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). , 1991, International journal of epidemiology.